Emergent BioSolutions said it hopes to respond to federal regulators within days on how to resolve the problems at its East Baltimore plant. It’s the same facility that ruined 15 million doses of the Johnson & Johnson coronavirus vaccine. The FDA halted production at Emergent, and earlier this month released a report on its concerns over cross-contamination and sanitation inside the facility.
Emergent Says Plan Coming Within Days To Fix J&J COVID Vaccine Mistake At Baltimore Plant
April 30, 2021